Department of Radiation Oncology, Institut Curie, Paris, France.
Department of Radiation Oncology, Institut Curie, Paris, France.
Cancer Radiother. 2024 Nov;28(6-7):510-512. doi: 10.1016/j.canrad.2024.07.004. Epub 2024 Sep 27.
There is new data in the fractionation modalities and these are the really the practice-changing trials of last years: can we use hypo fractionated whole breast radiotherapy in patients presented with ductal carcinoma in situ? Can we realize hypofractionated whole breast radiotherapy with simultaneous integrated boost? What about hypofractionated irradiation after mastectomy with reconstruction? Can we do hypofractionation to lymph nodes without risk of increased toxicity? The purpose of this work is to respond with the last evidence-based recently presented or published data.
在分割模式方面有新的数据，这些都是过去几年真正改变实践的试验：我们能否在患有导管原位癌的患者中使用低分割全乳腺放射治疗？我们能否使用同时整合增敏实现低分割全乳腺放射治疗？乳房切除术和重建后低分割照射如何？我们能否对淋巴结进行低分割而不增加毒性风险？这项工作的目的是用最近提出或发表的最新循证证据来回答。
